XML 41 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Derivatives and Hedging Activities (Tables)
 3 Months Ended
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Balance Sheet Category and Fair Value Schedule
The table below identifies the balance sheet category and fair value of the Company’s derivative instruments as of March 31, 2025 and December 31, 2024. The Company has a minimum collateral posting threshold with its derivative counterparty. If the Company had breached any provisions under the agreement as of March 31, 2025, it could have been required to settle its obligations under the agreement at the termination value.
March 31, 2025December 31, 2024
(dollars in thousands)Notional
Amount		Fair ValueBalance Sheet
Category		Notional
Amount		Fair ValueBalance Sheet
Category
Derivatives in an asset position:
Derivatives not designated as hedging instruments:
Interest rate product$750,082 $29,165 Other Assets$697,086 $31,592 Other Assets
Credit risk participation agreements49,480 — Other Liabilities49,480 — Other Liabilities
Total derivatives in an asset position$799,562 $29,165 $746,566 $31,592 
Derivatives in a liability position:
Derivatives not designated as hedging instruments:
Interest rate product$750,082 $26,447 Other Liabilities$697,086 $29,110 Other Liabilities
Schedule of the Effect of Derivative Financial Instruments on the Consolidated Statements of Operations
The tables below present the effect of the Company’s derivative financial instruments on the Consolidated Statements of Operations for the three months ended March 31, 2025 and 2024.
Effect of Derivatives Not Designated as Hedging Instruments on the Consolidated Statements of Operations
(dollars in thousands)Location of Gain or (Loss) Recognized in
Income on Derivative		Amount of Gain or (Loss) Recognized in Income on Derivatives
Three Months Ended March 31,
20252024
Derivatives Not Designated as Hedging Instruments under ASC 815-20:
Interest rate productsOther income / (expense)$(6)$239